; and (B) make changes to the proposed clinical pathway in response to any such comments received using the same process and criteria used to establish the proposed clinical pathway. (4) Collaboration and coordination In establishing the clinical pathway required under this section, the Secretary shall— (A) provide for consideration of other clinical pathways and research findings of other departments and agencies, including guidelines that are widely recognized and guidelines that are used as the standard for clinical policy in oncology care, such as National Comprehensive Cancer Network guidelines; and (B) collaborate and coordinate with— (i) the National Institutes of Health; (ii) the National Cancer Institute; (iii) the National Institute on Minority Health and Health Disparities; (iv) other Institutes and Centers as the Secretary determines necessary; (v) the Centers for Disease Control and Prevention; (vi) the Department of Defense; (vii) the Centers for Medicare and Medicaid Services; (viii) the Patient-Centered Outcomes Research Institute; and (ix) the Food and Drug Administration. (5) Publication The Secretary shall— (A) publish the clinical pathway established under this subsection on a publicly available Department website; and (B) regularly update the clinical pathway as needed by review of the medical literature and available evidence-based guidelines at least annually, in accordance with the criteria under paragraph (2). (b) Development of national cancer of the prostate clinical care implementation program (1) Establishment Not later than 90 days after the date of the enactment of this Act, the Secretary shall submit to Congress a plan to establish a comprehensive prostate cancer program. (2) Program requirements The com­pre­hen­sive prostate cancer program shall— (A) be multidisciplinary and include the authority to work across clinical care lines, specialties, and the organizational divisions of the Veterans Health Administration